The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Open accessAbstract
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD) is arguably the clearest instance of crosstalk between neurodegenerative and cerebrovascular processes. The pathogenic pathways of CAA and AD intersect at the levels of Aβ generation, its circulation within the interstitial fluid and perivascular drainage pathways and its brain clearance, but diverge in their mechanisms of brain injury and disease presentation. Here, we review the evidence for and the pathogenic implications of interactions between CAA and AD. Both pathologies seem to be driven by impaired Aβ clearance, creating conditions for a self-reinforcing cycle of increased vascular Aβ, reduced perivascular clearance and further CAA and AD progression. Despite the close relationship between vascular and plaque Aβ deposition, several factors favour one or the other, such as the carboxy-terminal site of the peptide and specific co-deposited proteins. Amyloid-related imaging abnormalities that have been seen in trials of anti-Aβ immunotherapy are another probable intersection between CAA and AD, representing overload of perivascular clearance pathways and the effects of removing Aβ from CAA-positive vessels. The intersections between CAA and AD point to a crucial role for improving vascular function in the treatment of both diseases and indicate the next steps necessary for identifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, brains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation [79], which can be seen in many AD patients with cerebral amyloid angiopathy [80].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Inflammation does, however, not seem to be a major component in CAA-related microhemorrhage or microinfarction [38], with the exception of a rare clinical subtype: CAA-related inflammation [6].”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [6]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“Chronic inflammation‐induced disruption of the BBB is an early biomarker of human cognitive dysfunction and often leads to dementia, 113 and both Aβ deposits and tau pathology aggravate vascular damage. 114 , 115”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [115]
In the citing paper
“There is overwhelming evidence for cerebrovascular alterations in AD pathology and amyloid-β deposition around leptomeningeal vessels is a hall mark of cerebral amyloid angiopathy, occurring in almost all AD patients”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Greenberg et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Self-citation
Cited by
Sorted by citations
Items 301–400 of 954
Interaction of Proteins Involved in Neuronal Proteinopathies
Kulichikhin, K. Y., Malikova, O. A., Zobnina, A. E., Zalutskaya, N. M., & Rubel, A. A. (2023) · Life · doi:10.3390/life13101954 · Cited by 17
Multi-perspective neural network for dual drug repurposing in Alzheimer’s disease
Zhao, L., Li, Z., Chen, G., Yin, Y., & Chen, C. Y. (2023) · Knowledge-Based Systems · doi:10.1016/j.knosys.2023.111195 · Cited by 17
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment
Saitô, S., Suzuki, K., Ohtani, R., Maki, T., Kowa, H., Tachibana, H., Washida, K., Kawabata, N., Mizuno, T., Kanki, R., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44938 · Cited by 17
Aslanyan, V., Mack, W. J., Ortega, N. E., Nasrallah, I. M., Pajewski, N. M., Williamson, J. D., & Pa, J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13572 · Cited by 17
de Kort, A. M., Verbeek, M. M., Schreuder, F. H. B. M., Klijn, C. J. M., & Jäkel, L. (2024) · Journal of Stroke · doi:10.5853/jos.2023.04287 · Cited by 17
History in perspective: How Alzheimer's Disease came to be where it is?
Ahmed, T. F., Ahmed, A., & Imtiaz, F. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147342 · Cited by 21
Abondio, P., Sarno, S., Giuliani, C., Laganà, V., Maletta, R., Bernardi, L., Bruno, F., Colao, R., Puccio, G., Frangipane, F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines10010020 · Cited by 17
Alten, B., Gökçal, E., Warren, A. D., van Veluw, S. J., Kozberg, M. G., Gurol, M. E., Viswanathan, A., & Greenberg, S. M. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.040025 · Cited by 16
Self-citationUchida, Y., Kano, Y., Kan, H., Sakurai, K., Morita, H., Akagawa, Y., Matsukawa, N., & Oishi, K. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100256 · Cited by 16
Vervuurt, M., de Kort, A. D., Jäkel, L., Kersten, I., Abdo, W. F., Schreuder, F., Rasing, I., Terwindt, G., Wermer, M., Greenberg, S., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01171-3 · Cited by 11
Self-citationMunis, Ö. B. (2023) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2023.22.3.87 · Cited by 16
Neurovascular coupling in early stage dementia – A case-control study
van Dijk, S. E., Drenth, N., Hafkemeijer, A., Labadie, G., Witjes‐Ané, M. W., Blauw, G. J., Rombouts, S. A. R. B., van der Grond, J., & van Rooden, S. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231214102 · Cited by 16
Chen, H. C., Cao, J., Zhang, Y.-S., Ma, Y., Zhang, L., Su, X., Gao, L., & Jing, Y. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109570 · Cited by 16
Cerebral amyloid angiopathy and the immune system
Munsterman, D., Falcione, S. R., Long, R., Boghozian, R., Joy, T., Camicioli, R. M., Smith, E. E., & Jickling, G. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13826 · Cited by 16
Loss of TREM2 diminishes CAA despite an overall increase of amyloid load in Tg‐SwDI mice
Zhong, R., Xu, Y., Williams, J. W., & Li, L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14222 · Cited by 16
Qi, W., Dong, N., Wu, P., Wenjun, F., Liu, Q., Zhang, X., Wu, H., He, X., Wu, L., Ward, N., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.103225 · Cited by 16
β-amyloid pathology is not associated with depression in a large community sample autopsy study
Saldanha, N. M., Suemoto, C. K., Rodriguez, R. D., Leite, R. E. P., Nascimento, C. F., Ferretti‐Rebustini, R. E. D. L., da Silva, M. M., Pasqualucci, C. A., Nitríni, R., Filho, W. J., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.062 · Cited by 16
Vettore, M., Marco, M. D., Pallucca, C., Bendini, M., Gallucci, M., & Venneri, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.737359 · Cited by 16
Gökçal, E., Horn, M. J., Becker, J. A., Das, A. S., Schwab, K. M., Biffi, A., Rost, N. S., Rosand, J. M., Viswanathan, A., Polimeni, J. R., et al. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221076571 · Cited by 17
Self-citationTang, C., Ding, Y., Yang, J., & He, D. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100209 · Cited by 15
Wang, Y., Yu, Q., Chen, B., Zhou, J., Li, Z., Liao, W., Liu, J., & Yang, A. (2025) · BMC Neurology · doi:10.1186/s12883-025-04302-5 · Cited by 15
Cerebral amyloid angiopathy: a narrative review
Noto, N. M., Speth, R. C., & Robison, L. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632252 · Cited by 17
Wang, W., Wang, L., Zhong, X., Dong, L., Zhang, L., & Hu, J. X. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70146 · Cited by 15
Arias, J. C., Edwards, M., Vitali, F., Beach, T. G., Serrano, G. E., & Weinkauf, C. C. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.07.238 · Cited by 15
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 17
Cerebral tau pathology in cerebral amyloid angiopathy
Tsai, H.-H. C., Liu, C., Lee, B., Chen, Y., Yen, R., Jeng, J., & Tsai, L. (2024) · Brain Communications · doi:10.1093/braincomms/fcae086 · Cited by 15
Hu, Z., Yang, J., Zhang, S., Li, M., Zuo, C., Mao, C., Zhang, Z., Tang, M., Shi, C., & Xu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01277 · Cited by 15
The Role of Aging in Intracerebral Hemorrhage
Huang, B., Chen, A., Sun, Y., & He, Q. (2024) · Brain Sciences · doi:10.3390/brainsci14060613 · Cited by 15
Kasri, A., Camporesi, E., Gkanatsiou, E., Boluda, S., Brinkmalm, G., Stimmer, L., Ge, J., Hanrieder, J., Villain, N., Duyckaerts, C. J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02756-4 · Cited by 16
Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
McCollum, L., Das, S. R., Xie, L., de Florès, R., Wang, J., Xie, S. X., Wisse, L. E. M., Yushkevich, P. A., & Wolk, D. A. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102717 · Cited by 15
Marcolini, S., Frentz, I., Sánchez-Catasús, C. A., Mondragón, J. D., Feltes, P. K., van der Hoorn, A., Borra, R., Ikram, M. A., Dierckx, R., & Deyn, P. P. D. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101661 · Cited by 16
Aldea, R., Grimm, H. P., Gieschke, R., Hofmann, C., Lott, D., Bullain, S., Delmar, P., Klein, G., Lyons, M., Piazza, F., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12306 · Cited by 15
Huang, W.-F., Hua, C., Guo, Y. H., Gao, W., Li, Y., & Zheng, Y. (2023) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2023.102198 · Cited by 16
Singh, P. K., Badimon, A., Chen, Z., Strickland, S., & Norris, E. H. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12504 · Cited by 17
Seed to Bleed: Iatrogenic Cerebral Amyloid Angiopathy
Greenberg, S. M., & Charidimou, A. (2023) · Stroke · doi:10.1161/strokeaha.123.042583 · Cited by 15
Self-citationPrediction of neuropathologic lesions from clinical data
Phongpreecha, T., Cholerton, B., Bukhari, S. A., Chang, A. L., Francesco, D. D., Thuraiappah, M., Godrich, D., Perna, A., Becker, M., Ravindra, N. G., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12921 · Cited by 14
Zhu, L. J., Wang, M., Liu, Y., Fu, P., Zhang, W., Zhang, H., Roe, A. W., & Wang, X. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112469 · Cited by 14
Lee, K., Kim, H., Lee, S. J., Duperron, M., Debette, S., Bae, H., & Sung, J. (2023) · Stroke · doi:10.1161/strokeaha.123.042980 · Cited by 14
Pomilio, C. J., Presa, J., Oses, C., Vinuesa, A., Bentivegna, M., Gregosa, A., Riudavets, M. A., Sevlever, G. E., Galván, V., Levi, V., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03897-5 · Cited by 15
Zsadanyi, S. E., Morcillo-Nieto, A. O., Aranha, M. R., Aragón, I., Arriola‐Infante, J. E., Vaqué‐Alcázar, L., Montal, V., Pegueroles, J., Arranz, J., Rodríguez‐Baz, Í., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209676 · Cited by 15
Gutierre, R. C., Rocha, P. R. M., Graciani, A. L., Ribeiro, A. A. C. M., & Arida, R. M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149419 · Cited by 14
Kučikienė, D., Costa, A. S., Banning, L. C. P., van Gils, V., Schulz, J. B., Ramakers, I. H. G. B., Verhey, F. R. J., Vos, S. J. B., & Reetz, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215391 · Cited by 14
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue
Zedde, M., Grisendi, I., Assenza, F., Vandelli, G., Napoli, M., Moratti, C., Lochner, P., Seiffge, D. J., Piazza, F., Valzania, F., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102663 · Cited by 14
De Kort, A. M., Kuiperij, H. B., Alcolea, D., Kersten, I., Versleijen, A. A. M., Greenberg, S. M., Stoops, E., Schreuder, F. H. B. M., Klijn, C. J. M., Lleó, A., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00899-0 · Cited by 13
Self-citationHermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience · doi:10.37349/en.2025.1006106 · Cited by 13
Ferrari, I., Limiti, E., Giannitelli, S. M., Trombetta, M., Rainer, A., D’Amelio, M., Barbera, L. L., & Gori, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199478 · Cited by 15
Grangeon, L., Roussel, M., Gillibert, A., Verdalle-Cazes, M., Dolores, M., Ozkul-Wermester, O., Gilard, V., Derrey, S., Maltête, D., Gérardin, E., et al. (2023) · Clinical Neuroradiology · doi:10.1007/s00062-022-01230-6 · Cited by 13
Liu, D., Hsueh, S., Tweedie, D., Price, N., Glotfelty, E. J., Lecca, D., Telljohann, R. S., de Cabo, R., Hoffer, B. J., & Greig, N. H. (2024) · Brain Communications · doi:10.1093/braincomms/fcae204 · Cited by 13
Lead Acetate Exposure and Cerebral Amyloid Accumulation: Mechanistic Evaluations in APP/PS1 Mice
Gu, H., Liu, L. L., Wu, A., Yu, Y., Emir, U. E., Sawiak, S. J., Territo, P. R., Farlow, M. R., Zheng, W., & Du, Y. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14384 · Cited by 14
Clinical 7 Tesla magnetic resonance imaging: Impact and patient value in neurological disorders
de Vries, E., Hagbohm, C., Ouellette, R., & Granberg, T. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20059 · Cited by 21
Huang, L., Liu, M., Li, Z., Li, B., Wang, J., & Zhang, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00865 · Cited by 13
Pokrzyk, J., Kulczyńska‐Przybik, A., Guzik-Makaruk, E. M., Winkel, I., & Mroczko, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051935 · Cited by 14
Development of a PET radioligand selective for cerebral amyloid angiopathy
Abrahamson, E. E., Stehouwer, J. S., Vazquez, A. L., Huang, G., Mason, N. S., Lopresti, B. J., Klunk, W. E., Mathis, C. A., & Ikonomović, M. D. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.05.001 · Cited by 13
Cerebral microbleeds in vascular dementia from clinical aspects to host-microbial interaction
Tonomura, S., & Gyanwali, B. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105073 · Cited by 13
Stepanchuk, A. A., Barber, P. A., Lashley, T., Joseph, J. T., & Stys, P. K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105540 · Cited by 13
Vascular Contributions to Brain Health: Cross-Cutting Themes
Greenberg, S. M. (2022) · Stroke · doi:10.1161/strokeaha.121.034921 · Cited by 13
Self-citationTaylor, H. A., Simmons, K. J., Clavane, E. M., Trevelyan, C. J., Brown, J., Przemyłska, L., Watt, N. T., Matthews, L. C., & Meakin, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094568 · Cited by 13
de Kort, A. M., Kuiperij, H. B., Jäkel, L., Kersten, I., Rasing, I., van Etten, E. S., van Rooden, S., van Osch, M. J. P., Wermer, M. J. H., Terwindt, G. M., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01245-2 · Cited by 13
Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort
Costa, A. S., Pinho, J., Kučikienė, D., Reich, A., Schulz, J. B., & Reetz, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201218 · Cited by 13
The brain neurovascular epigenome and its association with dementia
Ziegler, K. C., Askarova, A., Gergian, C., Yaa, R. M., van Dalen, J. D., Transfeld, J. L., Zoppi, F., Du, J., Clode, D., Rahbar, F., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.001 · Cited by 17
CSF markers of vascular injury correlate with tau and cognitive decline in early Alzheimer's disease
Miners, J. S., Roy, G., Love, S., & Initiative, A. F. T. A. D. N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70957 · Cited by 12
van Etten, E. S., Mahinrad, S., Grill, J. D., Salloway, S., Atri, A., Cogswell, P. M., Benzinger, T. L. S., Iwatsubo, T., Iadecola, C., Lemere, C. A., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71361 · Cited by 16
Self-citationSong, S., Li, X., Xue, X., Dong, W., & Li, C. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s456912 · Cited by 12
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12
Ma, Y., & Han, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00821 · Cited by 12
Tsai, H.-H. C., Pasi, M., Liu, C., Tsai, Y.-C., Yen, R., Chen, Y., Jeng, J., Tsai, L., Charidimou, A., & Baron, J. (2025) · Journal of Stroke · doi:10.5853/jos.2024.02376 · Cited by 12
Alves, L., Hashiguchi, D., Loss, C. M., van Praag, H., & Longo, B. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251321118 · Cited by 12
Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls
Muir, R. T., Stukas, S. K., Cooper, J. G., Beaudin, A. E., McCreary, C. R., Gee, M., Nelles, K., Nukala, N., Valencia, J., Kirmess, K. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70010 · Cited by 12
Kawakatsu, S., Kobayashi, R., Hayashi, H., Morioka, D., Utsunomiya, A., Kabasawa, T., Ohe, R., & Otani, K. (2021) · Neuropathology · doi:10.1111/neup.12765 · Cited by 12
High-Resolution Digital Panorama of Multiple Structures in Whole Brain of Alzheimer's Disease Mice
Yin, X., Zhang, X., Zhang, J., Yang, W., Sun, X., Zhang, H., Gao, Z., & Jiang, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.870520 · Cited by 12
Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease
Zou, X., Yuan, Y., Liao, Y., Jiang, C., Zhao, F., Ding, D., Gu, Y., Chen, L., Chu, Y., Hsu, Y., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12285 · Cited by 13
Muller, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1185267 · Cited by 12
Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
Ali, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Hadi, N. R., Assiri, A. A., Alrouji, M., Welson, N. N., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01489-y · Cited by 12
Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
Grossmann, K. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303029 · Cited by 13
Polak-Szabela, A., Dziembowska, I., Bracha, M., Pedrycz, A., Kędziora–Kornatowska, K., & Kozakiewicz, M. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s310750 · Cited by 11
Theodorou, A., Palaiodimou, L., Papagiannopoulou, G., Kargiotis, O., Psychogios, K., Safouris, A., Bakola, E., Chondrogianni, M. E., Kotsali-Peteinelli, V., Melanis, K., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175591 · Cited by 11
Lannfelt, L. (2023) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v128.10316 · Cited by 12
Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy
van den Berg, E., Kersten, I., Brinkmalm, G., Johansson, K., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Gobom, J., Stoops, E., Portelius, E., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16074 · Cited by 13
LEE, T., Leung, W. C. Y., Ho, C., Chiu, M. W., Leung, I. Y. H., Wong, Y., Roxanna, L. K., Sum, C. H. F., Lui, D. T. W., Cheung, R. T., et al. (2024) · International Journal of Stroke · doi:10.1177/17474930241239523 · Cited by 11
Wu, J., Liu, Z., Yao, M., Zhu, Y., Peng, B., & Ni, J. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12451-9 · Cited by 11
Silbert, L. C. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001508 · Cited by 11
Downes, M., Kalagara, R., Rossitto, C. P., Vasan, V., Vasa, D., Chennareddy, S., Lefton, D. R., Yıldız, S., Umphlett, M., Brockington, C., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213460 · Cited by 11
Li, X., Qiu, Y., Zhou, J. H., & Xie, Z. (2021) · Current Genomics · doi:10.2174/1389202923666211216163049 · Cited by 11
Wolters, F. J., Hilal, S., Leening, M. J. G., Kavousi, M., Ghanbari, M., Franco, O. H., Albert Hofman, D., Koudstaal, P. J., Vernooij, M. W., Ikram, M. K., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.025 · Cited by 11
Focus on Alzheimer’s Disease: The Role of Fibroblast Growth Factor 21 and Autophagy
Yang, L., & Nao, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.003 · Cited by 11
Bonaterra‐Pastra, A., Benítez, S., Pancorbo, O., Rodríguez‐Luna, D., Vert, C., Rovira, À., Freijo, M. D. M., Tur, S., Martínez-Zabaleta, M., Portela, P. C., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1134399 · Cited by 11
Incidence and risk factors associated with seizures in cerebral amyloid angiopathy
Freund, B. E., Sánchez, S. S., Blackmon, K., Day, G. S., Lin, M., Khan, A., Feyissa, A. M., Middlebrooks, E. H., & Tatum, W. O. (2023) · European Journal of Neurology · doi:10.1111/ene.15903 · Cited by 11
Pinho, J., Almeida, F., Araújo, J. M., Machado, Á. S., Costa, A. S., Silva, F., Francisco, A., Quintas-Neves, M., Ferreira, M. D. C., Soares-Fernandes, J. P., et al. (2023) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7900 · Cited by 11
Banerjee, S., Naik, T., Baghel, D., & Ghosh, A. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01869 · Cited by 11
Lee, D.-H., Ryoo, J. E., Hong, S., Kim, H. Y., & Kim, Y. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-36167-4 · Cited by 11
Yubolphan, R., Pratchayasakul, W., Koonrungsesomboon, N., Chattipakorn, N., & Chattipakorn, S. C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114683 · Cited by 11
Yamazaki, A., Sekine, T., Takahashi, S., Sohara, K., Sakamaki, M., Nagao, T., Kimura, K., & Mishina, M. (2024) · Psychogeriatrics · doi:10.1111/psyg.13231 · Cited by 11
Dual-Stream Subspace Clustering Network for revealing gene targets in Alzheimer's disease
Chen, M., Jia, S., Xue, M., Huang, H., Xu, Z., Yang, D., Zhu, W., & Song, Q. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106305 · Cited by 12
Imaging of Amyloid-Related Imaging Abnormalities (ARIA)
Urbach, H., Linn, J., Hattingen, E., & Fiebach, J. B. (2023) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-2185-8472 · Cited by 10
Pucci, I. M., Aguiar, A. F., Pucci, R. M., Casonatto, J., & Borghi, S. M. (2024) · Experimental Brain Research · doi:10.1007/s00221-024-06821-y · Cited by 12
Cerebral amyloid angiopathy: one single entity?
Koemans, E. A., & van Etten, E. S. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001330 · Cited by 10
Sun, K. T., & Mok, S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00512 · Cited by 12
Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update
Weidauer, S., & Hattingen, E. (2025) · Biomedicines · doi:10.3390/biomedicines13030603 · Cited by 11
Kakeda, S., Miki, Y., Kudo, K., Mori, H., Tokumaru, A. M., Abe, O., Aoki, S., & Working Group for Brain MRI Guidelines for Anti-Aβ Antibody Treatment from The Japan Radiological Society, T. J. S. F. N. (2025) · Japanese Journal of Radiology · doi:10.1007/s11604-025-01773-x · Cited by 10
Hu, M., Yi, H., Wang, S., Kang, X., Liu, Y., Liu, Z., Huang, H., Qin, Q., Yuan, L., Cai, W., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01273 · Cited by 10
Metadata
- Authors
- Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Greenberg, Steven M.
- Venue
- Nature Reviews Neurology
- Published
- 2019-12-11
- Volume
- 16
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC7268202
- OpenAlex
- W2995183059
- Cited by
- 947
- References
- 232
- Citations by year
- 2026: 146 · 2025: 198 · 2024: 179 · 2023: 154 · 2022: 113 · 2021: 104 · 2020: 52
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG026484)
- National Institute of Neurological Disorders and Stroke (RF1NS110054, R01NS096730, U24NS100591)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, amyloid-beta, amyloid-beta clearance, amyloid-related imaging abnormalities, anti-amyloid immunotherapy, vascular function
- MeSH terms
- Alzheimer Disease, Brain, Humans, Signal Transduction, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
